Vitamin C Kills Drug-Resistant Tuberculosis in Lab Trials

Vitamin C can kill multidrug-resistant tuberculosis in the lab, scientists have found.

The surprise discovery may point to a new way of tackling this increasingly hard-to-treat infection, the U.S. study authors from Yeshiva University say in Nature Communications.

An estimated 650,000 people worldwide have multidrug-resistant TB.

Studies are now needed to see if a treatment that works using the same action as vitamin C would be useful as a TB drug in humans.

Early work

In the laboratory studies, vitamin C appeared to be acting as a “reducing agent” – something that triggers the production of a reactive oxygen species called free radicals. These free radicals killed off the TB, even drug resistant forms that are untreatable with conventional antibiotics such as isoniazid.

Lead investigator Dr William Jacobs, professor of microbiology and immunology at Albert Einstein College of Medicine at Yeshiva University, said: “We have only been able to demonstrate this in a test tube, and we don’t know if it will work in humans and in animals.

“This would be a great study to consider because we have strains of tuberculosis that we don’t have drugs for, and I know that in the laboratory we can kill those strains with vitamin C.

“It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB.”

Potential treatment

It might be that vitamin C could be used alongside TB drugs. Alternatively, scientists could create new TB drugs that work by generating a big burst of free radicals.

Vitamin C, or ascorbic acid, has many important functions in the body, including protecting cells and keeping them healthy.

Good natural sources of the vitamin include oranges, blackcurrants and broccoli and most people get all they need from their diet.

Dr Ibrahim Abubakar, head of TB at Public Health England, said: “We welcome any new research which will widen our understanding of how to treat TB. While the findings of this study appear promising, further research to confirm the observations would be essential before Vitamin C can be used to supplement TB treatment.”

Source: bbc.co.uk

Subscribe To The ABS Newsletter — Get our stories in your inbox.

Independent journalism still matters.

We hope this story was worth your time. For over 14 years, Atlanta Black Star has stayed Black-owned and independently run. We didn't get here by waiting on ad budgets that were never built to prioritize us. Our readers did that.

Corporate support for Black media has always been thin. Outlets like ours get roughly 1% of the $170 billion spent on U.S. advertising each year, and that margin is shrinking further as advertisers walk back the DEI-linked commitments they made in 2020. That's the backdrop. It's not why we're asking.

The wider picture isn't any steadier. Newspaper ad revenue has fallen more than 80% since 2005, and local newsrooms are closing at a rate of roughly two a week nationwide. When outlets go under, it's rarely the ones built to center a Black perspective from the ground up that get to stick around.

We know a request for support isn't why you came here. But without readers choosing to fund this work directly, the depth of reporting we can do at home and abroad shrinks along with everyone else's. If you're not in a position to give, that doesn't change how much we value you as a reader.

If you are able to, a recurring contribution does more for us than a single one-time gift, because it lets us plan the next investigation instead of just the next invoice. It takes about 30 seconds, no long form, no account. Thank you for continuing to support independent journalism and freedom of the press.

Latest from Atlanta Black Star

Back to top